Quoin Pharmaceuticals, Ltd. (QNRX)
NASDAQ: QNRX · Real-Time Price · USD
6.06
-0.54 (-8.18%)
At close: Apr 1, 2026, 4:00 PM EDT
5.94
-0.12 (-1.98%)
After-hours: Apr 1, 2026, 4:28 PM EDT
Quoin Pharmaceuticals Market Cap
Quoin Pharmaceuticals has a market cap or net worth of $10.2 million as of April 1, 2026. Its market cap has increased by 68.01% in one year.
Market Cap
10.20M
Enterprise Value
-5.31M
1-Year Change
68.01%
Ranking
Category
Stock Price
$6.06
Market Cap Chart
Since October 29, 2021, Quoin Pharmaceuticals's market cap has decreased from $97.17M to $10.20M, a decrease of -89.50%. That is a compound annual growth rate of -39.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 10.57M | -12.66% |
| Dec 31, 2025 | 12.11M | 127.24% |
| Dec 31, 2024 | 5.33M | 10.02% |
| Dec 29, 2023 | 4.84M | -29.65% |
| Dec 30, 2022 | 6.88M | -54.69% |
| Dec 31, 2021 | 15.19M | -84.36% |
| Oct 29, 2021 | 97.17M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chemomab Therapeutics | 11.31M |
| NewcelX | 10.90M |
| Cellectar Biosciences | 10.85M |
| BioAtla | 10.78M |
| BioLineRx | 10.75M |
| Acurx Pharmaceuticals | 10.69M |
| BioVie | 10.56M |
| Imunon | 10.15M |